AVBP Competitors & Alternatives
Compare ArriVent BioPharma, Inc. Common Stock with similar stocks in the same industry
Biotechnology
AVBP
Main Stock$29.00
Tradestie Score
42
Market Cap
$748.90M
Analyst Upside
+54.1%
Top Competitors
233 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AUPH
Aurinia Pharmaceuticals Inc
|
$16.10
|
$1.50B | 7.1 | 53 | Compare |
|
GPCR
Structure Therapeutics Inc. American Depositary Shares
|
$38.66
|
$1.50B | - | 41 | Compare |
|
AMLX
Amylyx Pharmaceuticals, Inc. Common Stock
|
$31.62
|
$1.49B | - | 40 | Compare |
|
RCUS
Arcus Biosciences, Inc.
|
$24.59
|
$1.43B | - | 42 | Compare |
|
JANX
Janux Therapeutics, Inc. Common Stock
|
$17.10
|
$1.42B | - | 41 | Compare |
|
SNDX
Syndax Pharmaceuticals, Inc.
|
$18.18
|
$1.35B | - | 46 | Compare |
|
RAPP
Rapport Therapeutics, Inc. Common Stock
|
$43.62
|
$1.32B | - | 47 | Compare |
|
XERS
Xeris Biopharma Holdings, Inc. Common Stock
|
$7.45
|
$1.29B | - | 47 | Compare |
|
STOK
Stoke Therapeutics, Inc. Common Stock
|
$29.03
|
$1.29B | - | 57 | Compare |
|
ARDX
Ardelyx, Inc.
|
$3.58
|
$1.29B | - | 40 | Compare |
More AVBP Analysis
Data updated: Sep 12, 2026 | Industry: Biotechnology (SIC 2834)
233 stocks in this industry